Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14720
Articles
Company
Drug
Fujian Cosunter Completes Enrollment for Phase I Study of GST-HG171
January 28, 2025
Company
Drug
Alphamab Oncology Updates Clinical Studies for KN046 and KN026 at SABCS 2022
January 28, 2025
Company
Deals
Roche and Zhongshan Hospital Collaborate on Clinical Studies and Innovation Center
January 28, 2025
Company
Drug
ASH 2022: China Biotechs Showcase Latest Clinical Trial Results
January 28, 2025
Company
Deals
Merck Partners with Tsinghua Shenzhen for Organoid 3D Printing System
January 28, 2025
Company
Deals
Luye Pharma Group Hands Over Seroquel Distribution Rights to DCH Auriga in Singapore
January 28, 2025
Company
Drug
RemeGen’s RC118 Receives Orphan Drug Designations for Gastric and Pancreatic Cancers
January 29, 2025
Company
Drug
Innovent Biologics Presents Clinical Study Results at ESMO-IO 2022
January 29, 2025
Policy / Regulatory
NMPA Extends Validation Period for COVID-19 Antigen Detection Reagents
January 29, 2025
Company
Deals
Science Standard Medical Testing Raises Pre-Series A Funding
January 29, 2025
Company
Deals
Phanes Therapeutics and BeiGene Partner on Phase I Study of PT199
January 29, 2025
Company
Deals
XtalPi Partners with CTTQ for AI-Driven Small-Molecule Drug Development
January 29, 2025
1
2
…
1,098
1,099
1,100
1,101
1,102
…
1,226
1,227
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?